Mean Absolute Relative Difference– tag –
-
FDA Reiterates No Non-Invasive Glucose Monitors Approved; Tech Giants Pursue Inferential Wearables
Medium (Sahha AI Blog) USA Overview As of September 2026, the FDA has reiterated that no non-invasive glucose monitoring devices are approved, cautioning consumers against smartwatches or rings claiming to measure blood sugar without ski... -
Dexcom G7 Achieves Industry-Leading Accuracy with MARD 8.2-8.5% in Adults, Clinical Data Confirms
diabetesknow.com USA Overview Newly compiled clinical data for 2026 ranks the Dexcom G7 as the most accurate continuous glucose monitor (CGM), reporting a mean absolute relative difference (MARD) of approximately 8.2–8.5% in adults. This... -
Precision and Provenance: Why Regulatory Approval and MARD Transparency Define the Future of Glucose Monitoring
Mattioli 1885 イタリア Overview A recent report on the 2026 glucose monitoring market highlights the transformative role of Continuous Glucose Monitoring (CGM) in diabetes management. It underscores that robust quality indicators—specifi... -
Dexcom G7 15 Day Secures FDA Clearance: Longest-Lasting, Highly Accurate CGM System Redefines Diabetes Management
Dexcom News Release USA Overview Dexcom announced FDA clearance for its G7 15 Day, the longest-lasting (15 days) and most accurate continuous glucose monitoring (CGM) system for people with diabetes aged 18 and older. Boasting an impress...
1